Inactive Instrument

Other languages Lightlake Therapeutics OTC Bulletin Board

Equities

US53224T1051

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

2023	Indivior completes acquisition of Opiant Pharmaceuticals	AN
2023	Indivior Wraps Up Deal to Buy Opiant Pharmaceuticals	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Indivior completes acquisition of Opiant Pharmaceuticals	23-03-02
Indivior Wraps Up Deal to Buy Opiant Pharmaceuticals	23-03-02
Indivior PLC completed the acquisition of Opiant Pharmaceuticals, Inc. from a group of shareholders.	23-03-01
Indivior Wins US Regulatory Nod To Acquire Opiant Pharmaceuticals	23-02-07
Bolsa de Madrid: Jerome vuelve en la segunda semana	23-02-07
Jerome revient en deuxième semaine	23-02-07
En Direct des Marchés : BNP Paribas, TotalEnergies, L'Oréal, Scor, Casino, CVS, Bayer, Siemens, BP...	23-02-07
Indivior announces expiry of waiting period for Opiant purchase	23-02-06
Opiant Pharmaceuticals Says Waiting Period Expires for Proposed Takeover by Indivior Expires	23-02-06
Indivior Nears Acquisition of Opiant Pharmaceuticals	23-02-06
Warren tells FTC she is "particularly concerned" about Amgen and Indivior deals	23-01-26
Opiant Pharmaceuticals Granted FDA Priority Review for Opioid Overdose Therapy	23-01-20
Opiant Pharmaceuticals Announces FDA Acceptance and Priority Review of NDA for OPNT003, Nasal Nalmefene, for Opioid Overdose	23-01-19
Insider Sell: Opiant Pharmaceuticals	23-01-05
Opiant Pharmaceuticals Completes Rolling Submission of New Drug Application for Potential Opioid Overdose Drug	22-11-23
Opiant Pharmaceuticals, Inc. Announces Completion of Rolling NDA Submission for OPNT003, Nasal Nalmefene, for Opioid Overdose	22-11-22
MÄRKTE USA/Leichter - Anleger agieren zurückhaltend	22-11-14
Top Midday Gainers	22-11-14
MÄRKTE USA/Uneinheitlich - Anleger sind vorsichtig	22-11-14
MÄRKTE USA/Uneinheitlich - S&P-500 und Nasdaq mit Abgaben	22-11-14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Lightlake Therapeutics OTC Bulletin Board

Equities

US53224T1051

Other languages

Filters